vinpocetine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Fan, C; Guo, X; Hou, B; Jiang, C; Li, D; Ren, H; Wan, Z; Wang, D; Wang, G; Yan, G; Zhao, L | 1 |
| Gao, Y; Han, D; Liu, H; Sun, M; Wang, J; Wen, L | 1 |
2 other study(ies) available for vinpocetine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
Topics: Animals; Brain Ischemia; Infarction, Middle Cerebral Artery; Inflammasomes; Ischemic Stroke; Mice; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Reperfusion Injury; Signal Transduction; Sulfonamides | 2023 |
Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice.
Topics: Animals; Anti-Inflammatory Agents; Brain; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammasomes; Inflammation Mediators; Interleukin-18; Interleukin-1beta; Ischemic Stroke; Male; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Vinca Alkaloids | 2020 |